DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Comparison of Patch Vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Information source: Watson Pharmaceuticals
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Menopause

Intervention: Premarin® (oral) vs. Alora® (transdermal) (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Watson Pharmaceuticals

Official(s) and/or principal investigator(s):
Jan L Shifren, MD, Principal Investigator, Affiliation: Massachusetts General Hospital

Summary

This study compares the effects of 12 weeks of treatment with transdermal versus oral estrogen therapy on testsoterone levels and thyroid tests in healthy, naturally menopausal women.

Clinical Details

Official title: A Comparison of Transdermal Vs. Oral Estrogen Replacement Therapy on Androgen Levels and Thyroid Function in Naturally Menopausal Women

Study design: Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Pharmacokinetics Study

Primary outcome: Compare the effects of a 12-week course of oral CEE to a 12-week course of transdermal estradiol on free testosterone concentrations in menopausal women.

Secondary outcome:

Compare the effects of oral versus transdermal ERT on thyroid binding globulin concentrations and tests of thyroid function.

Compare the effects of oral versus transdermal ERT on cortisol binding globulin and total and free cortisol concentrations.

Eligibility

Minimum age: 42 Years. Maximum age: 70 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Healthy

- Naturally menopausal women

- Aged 42-70 years

- Currently using combination estrogen-progestin replacement therapy

Exclusion Criteria:

- Women with contraindications to HRT use, including: Unexplained vaginal bleeding, liver

disease, breast or endometrial cancer, venous thromboembolic events

- Thyroid disease

- Adrenal disease

Locations and Contacts

Massachusetts General Hospital, Boston, Massachusetts 02114, United States
Additional Information

Starting date: January 2002
Last updated: September 14, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009